Entrectinib in patients with ROS1-positive NSCLC or NTRK fusion-positive solid tumors with CNS metastases Meeting Abstract


Authors: Paz-Ares, L.; Dziadziuszko, R.; Drilon, A.; John, T.; Krebs, M.; Demetri, G.; Shaw, A.; Siena, S.; Wolf, J.; Farago, A.; Simmons, B.; Ye, C.; Huang, X.; Doebele, R.
Abstract Title: Entrectinib in patients with ROS1-positive NSCLC or NTRK fusion-positive solid tumors with CNS metastases
Meeting Title: 20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC)
Journal Title: Journal of Thoracic Oncology
Volume: 14
Issue: 10 Suppl.
Meeting Dates: 2019 Sept 7-10
Meeting Location: Barcelona, Spain
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2019-10-01
Start Page: S305
Language: English
ACCESSION: WOS:000492162201296
DOI: 10.1016/j.jtho.2019.08.611
PROVIDER: wos
Notes: Meeting Abstract: MA14.02 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon
Related MSK Work